Chronic lymphocytic leukemia in China
Open Access
- 11 October 2021
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Chinese Medical Journal
- Vol. 135 (8), 883-886
- https://doi.org/10.1097/cm9.0000000000001811
Abstract
An abstract is unavailable. This article is available as a PDF only.Keywords
This publication has 42 references indexed in Scilit:
- Preservation of lower incidence of chronic lymphocytic leukemia in Chinese residents in British Columbia: a 26-year survey from 1983 to 2008Leukemia & Lymphoma, 2013
- The Incidence of Leukemia, Lymphoma and Multiple Myeloma among Atomic Bomb Survivors: 1950–2001Radiation Research, 2013
- Comprehensive assessment of prognostic factors predicting outcome in Chinese patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamideMedical Oncology, 2011
- Lymphoid Malignancies in U.S. Asians: Incidence Rate Differences by Birthplace and AcculturationCancer Epidemiology, Biomarkers & Prevention, 2011
- The incidence of chronic lymphocytic leukemia in Taiwan, 1986-2005: a distinct increasing trend with birth-cohort effectBlood, 2010
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trialThe Lancet, 2010
- Genetic susceptibility for chronic lymphocytic leukemia among Chinese in Hong KongEuropean Journal of Haematology, 2010
- High incidence of hepatitis B virus infection in B‐cell subtype non‐Hodgkin lymphoma compared with other cancersCancer, 2007
- Genomic Aberrations and Survival in Chronic Lymphocytic LeukemiaThe New England Journal of Medicine, 2000
- Incidence of Leukaemia in Singapore, and Rarity of Chronic Lymphocytic Leukaemia in ChineseBMJ, 1960